Phenylketonuria (PKU): Molecular Advances in Pathophysiology and Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 August 2024) | Viewed by 1103
Special Issue Editors
2. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
3. Instituto Universitario de Biología Molecular UAM (IUBM), Madrid, Spain
4. Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain
Interests: metabolic diseases; molecular biology; genetics; proteins; enzyme replacement therapy
Special Issue Information
Dear Colleagues,
Phenylketonuria (PKU), a well-known inheritance disorder caused by the deficiency or absence of phenylalanine hydroxylase (PAH), is an autosomal recessive disorder of phenylalanine metabolism, in which especially high phenylalanine concentrations cause neurological dysfunction. If it remains untreated, severe intellectual disability, epilepsy and behavioral problems arise. Early diagnosis is based on newborn screening, and if treatment is started early and continued neurocognitive function is preserved. Dietary restriction of phenylalanine has been the main treatment option for the last decades until new therapeutic options have arouse such as pharmacological (tetrahydrobiopterin), and enzyme therapy (pegylated phenylalanine ammonia lyase, PALYNZIQTM). Other are under development, such as mRNA and gene therapy. Even though PAH deficiency is the most common defect of amino acid metabolism, the pathophysiology of PKU is still not completely understood, and further research is required to improve therapeutic options.
This Special Issue aims to provide new insights into molecular advances of the pathophysiology of the metabolic disease Phenylketonuria and the insights into the therapeutic options and new approaches currently under clinical development.
In this Special Issue, original scientific research articles and reviews are welcome. Research areas may include (but not limited to) the following: communications, case reports, letters, commentaries, editorials, etc.
We are pleased to invite you to contribute to this special issue and improve the knowledge of this paradigmatic disease.
We look forward to receiving your contributions.
Dr. Alejandra Gamez
Dr. Sandra Brasil
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phenylketonuria
- metabolic disease
- rare disease
- pharmacological chaperones
- enzyme therapy
- gene therapy
- RNA therapy
- DNAJ
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
